Steris Corp (NYSE:STE)

CAPS Rating: 3 out of 5

The Company is a provider of infection prevention and surgical products and services, focused primarily on the critical markets of healthcare, pharmaceutical and research.

Results 1 - 19 of 19

Recs

0
Member Avatar Petebmc (< 20) Submitted: 3/7/2014 3:30:42 PM : Outperform Start Price: $46.97 STE Score: +10.84

Steris is posturing to purchase IMS of. Birmingham a privately owned repair company with gross earning over 100 million. This will put Steris with their previous purchases of TRE and Spectrum Surgical as one of the largest repair companies in the United States

Recs

0
Member Avatar ethwc (69.62) Submitted: 1/10/2014 10:04:56 AM : Outperform Start Price: $48.52 STE Score: +4.54

I have had stock in STE since around 1994 when I first evaluated their product and fell in love with it. In looking at it again today, I see several "plusses." First, there is almost no discussion about STE on the commentary page indicating to me that it is a boring security and, therefore unlikely to be pushed around be day traders and their buddies. Second, I looked through the 123 or so having it on their CAPS list. Virtually all those with significant losses on this CAP pick were those who picked it to be a loser. No one seems to be a big time winner but many are up on the market in the 10 to 20 range. To me, a stock that gives a nice advantage to the market over a period of years is good.

Recs

0
Member Avatar wan65 (< 20) Submitted: 5/26/2009 3:35:33 PM : Outperform Start Price: $19.99 STE Score: +53.54

Dividend increase....Lowering costs... Safe business.

Recs

0
Member Avatar AnnaLisaCupcake (< 20) Submitted: 4/17/2009 9:46:01 AM : Outperform Start Price: $21.51 STE Score: +22.32

Got to keep the hospitals clean.

Recs

0
Member Avatar tickertale (47.95) Submitted: 2/4/2009 11:43:25 AM : Outperform Start Price: $23.29 STE Score: -3.28

A good defensive (industry) and offensive (earnings) play that is right for this mrkt.

Recs

0
Member Avatar WilliamCrook2007 (< 20) Submitted: 11/20/2008 2:47:04 PM : Outperform Start Price: $23.13 STE Score: -20.96

ibd

Recs

3
Member Avatar imagasser (< 20) Submitted: 11/12/2008 5:50:46 PM : Underperform Start Price: $26.05 STE Score: +25.72

Their System I processor was modified and the FDA rejected the modification and has told Steris they must re-apply for their 510K. With another product on the horizon, (the Manzi sterilizer www.licsystems.com). they may be forced to buy the Manzi sterilizer which was approved by the FDA and has set the new standard for what it means to be "sterile". No other processor on the market (or in development) can meet the new standard.
Steris may elect to buy the Manzi system to stay in the growing "lumened device" sterilization business. This may require a cash outlay to buy Manzi. ($600-900 Million)

Recs

0
Member Avatar lkmcy41 (< 20) Submitted: 7/12/2008 1:05:07 AM : Underperform Start Price: $26.12 STE Score: -45.96

- haven't confirmed where their sales growth comes from in conference calls. NUMBERS

Is it their sterlizers?? Too much controversy and not sure they are up for a legal battle- FDA sends a letter and then ironically a lawsuit follows which seems they don't have a prayer.

Where are they in relationshipo to their competition??

Recs

0
Member Avatar minh1616 (73.89) Submitted: 6/30/2008 1:16:23 PM : Outperform Start Price: $24.33 STE Score: +65.53

why not?

Recs

3
Member Avatar PennyPincher12 (98.78) Submitted: 6/23/2008 10:24:27 PM : Outperform Start Price: $24.74 STE Score: +64.89

Working at a drug manufacturing division at a small biotech company, we use a lot of Steris products. We go through about 10 bottles of IPA a day, not to mention what the other sectors of the business use. They also make SporKlenz, Vesphene, and LpH, great disinfects and basically the standards for clean room use. I know this isn't based on numbers but the products have a good following by their customers, and we will probably never switch brands. We just reoder Steris products without even checking out the competition. They have good pricing power and the demand for their products is growing each year as the business in general increases. The stock is priced 24 times earnings which is a bit much for a classic defensive Graham investor but I understand this company well and I think they have great future earning potential. The value of the shares is 1.7B and I see this as a bargain.

Recs

0
Member Avatar jersegyrl (43.44) Submitted: 3/17/2008 10:55:57 AM : Outperform Start Price: $22.36 STE Score: +83.84

Steris is a company that develops and produces technology and services that are used globally to prevent infection and other types of contamination. The company is continuing to experience growth in the 4-6% range. The company has also recently authorized a stock repurchase program. This can signify that the company believes that their own stock is their best investment and also desire to drive earnings per share higher.

Recs

0
Member Avatar AcubanFOOL (89.72) Submitted: 12/10/2007 11:53:49 AM : Outperform Start Price: $23.88 STE Score: +91.83

30.75/36 -26.5

Recs

0
Member Avatar movavg (59.42) Submitted: 10/29/2007 4:19:34 PM : Outperform Start Price: $24.47 STE Score: +87.88

Focus on sterlization given concerns around antibotic resistance germs will drive significant growth in next year

Recs

1
Member Avatar DavidHarvey2007 (76.19) Submitted: 6/21/2007 9:35:27 PM : Outperform Start Price: $24.75 STE Score: +81.82

Insider info there have been some devlopements in sterilization of buildings, After outbreaks or attacks anthrax etc. This will be opened as a service and contracted widely. Ok this stock wont go wild but it will hold steady and rise slowly for sure 5yrs +

possible new CEO

Recs

1
Member Avatar NetscribeMedDevs (95.09) Submitted: 3/12/2007 7:25:43 AM : Outperform Start Price: $21.27 STE Score: +106.94

STERIS Corporation develops, manufactures, and markets infection prevention, contamination control, microbial reduction, and surgical and critical care support products and services for healthcare, pharmaceutical, scientific, research, industrial, and governmental customers throughout the world. The company operates in three business segments: Healthcare, Life Sciences, and STERIS Isomedix Services.

The company posted a 4% revenue growth in the third quarter of 2007 with a strong order

Patterns, resulting in overall Healthcare backlog being at record levels, 21% up on year on year basis. This strong order pipeline promises the growth of the company for the coming several quarters. Additionally during these nine months the company has also completed expansions that added 10% in additional ethylene-oxide capacity at three of its smaller existing facilities. This additional capacity is expected to begin to have positive impact on revenues in fiscal 2008. Moreover the range of initiatives taken up by the company is gaining momentum and its new product flow is also improving which is expected to deliver both near-term and long-term results and value.

The demand in pharmaceutical equipment and consumables is expected to be positive with strong expansion in emerging markets. The company seems to well-positioned to garner the maximum on account of strong growth in the U.S. where several new pharma and biotech facilities are expected to be on the roll by the end of 2007. On the back of these facts the company is expected to bode well in the future and live up to the investors’ expectations.

Recs

0
Member Avatar sammyoz (< 20) Submitted: 2/17/2007 10:02:35 AM : Outperform Start Price: $22.54 STE Score: +97.79

Germs abound.

Recs

0
Member Avatar asu4232 (< 20) Submitted: 2/15/2007 11:49:49 PM : Underperform Start Price: $22.44 STE Score: -98.66

Because some big player will buy them for their Automatic washer business and the enzymatics they sell to enhance their present infection prevention business.

Recs

0
Member Avatar Unperdido (38.41) Submitted: 1/3/2007 11:32:11 PM : Outperform Start Price: $21.30 STE Score: +107.38

STE is a provider of infection control products. As the treat of bird flu looms and spread around the world this company will be a direct beneficiary

Recs

0
Member Avatar stans1pick (55.09) Submitted: 11/20/2006 9:40:46 AM : Underperform Start Price: $22.18 STE Score: -96.25

We move to mexico, the competion moves to china...

Results 1 - 19 of 19

Featured Broker Partners


Advertisement